Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

ZOETIS INC (ZTS)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 11/22 07:04:53 pm
71.145 USD   -0.30%
11/02 ZOETIS : beats Street 3Q forecasts
11/02 ZOETIS : Announces Third Quarter 2017 Results
10/30ZOETIS INC : quaterly earnings release
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ZOETIS INC
11/02 ZOETIS : beats Street 3Q forecasts
11/02 ZOETIS : Announces Third Quarter 2017 Results
10/30ZOETIS INC : quaterly earnings release
10/25 ZOETIS : Three Ways Aquaculture Can Learn From Livestock Animal Health
10/18 ZOETIS : Named a Best Company in Brazil
10/06 ZOETIS : to Participate in the Credit Suisse Healthcare Conference
10/06 ZOETIS INC. (NYSE : ZTS) announces a quarterly dividend of $0.11
10/05 ZOETIS INC. (NYSE : ZTS) Files An 8-K Regulation FD Disclosure
10/05 ZOETIS : Declares Fourth Quarter 2017 Dividend
10/04 ZOETIS : Generic Drugs Stock Performance Review -- Momenta Pharma, Medicines Co...
10/03 ZOETIS : seeks outstanding veterinary students for 2018 scholarships
09/29 ZOETIS : to Host Webcast and Conference Call on Third Quarter 2017 Financial Res..
09/26 ZOETIS : Working Mother Magazine Names Zoetis a Top Ten Company for 2017
09/26 ZOETIS : Named a Top Ten Company for Working Mothers
09/25 ZOETIS : to Participate in the Cantor Fitzgerald Global Healthcare Conference
More most relevant news
All news about ZOETIS INC
11/21 ZOETIS : Reports from Zoetis Inc. Provide New Insights into Gastroenterology (Us..
11/08 ZOETIS : SFE Investment Counsel Reduces Position in Zoetis Inc
11/02 ZOETIS : Management's Discussion and Analysis of Financial Condition and Results..
11/02 ZOETIS : beats Street 3Q forecasts
11/02 ZOETIS INC. : Results of Operations and Financial Condition (form 8-K)
11/02 ZOETIS : Announces Third Quarter 2017 Results
10/30ZOETIS INC : quaterly earnings release
10/25 ZOETIS : Three Ways Aquaculture Can Learn From Livestock Animal Health
10/19 ZOETIS : to Participate in the Credit Suisse Healthcare Conference
10/18 ZOETIS : Named a Best Company in Brazil
More news
Sector news : Veterinary Drugs
06:07p European shares retreat on euro bounce; UK flat after budget
05:56p FTSE gets sterling boost, land purchase threat dents housebuilders
09:50a U.S. FDA approves first two-drug HIV regimen in win for GSK
11/21 Brexit gets real for drugmakers as regulator moves to Amsterdam
11/21 Exclusive - Prescient messages about Indian companies circulate in WhatsApp g..
11/20 ASTRAZENECA : EU drugs agency move to Amsterdam minimizes likely staff losses
More sector news : Veterinary Drugs
News from SeekingAlpha
11/17 Tracking George Soros's Portfolio - Q3 2017 Update
11/17 DIVIDEND CHALLENGERS (AND NEAR-CHALL : 58 Increases Expected By The End Of Janua..
11/14 Tracking William Von Mueffling's Cantillon Capital Management Portfolio - Q3 ..
11/05 Zoetis 2017 Q3 - Results - Earnings Call Slides
11/02 Zoetis (ZTS) Q3 2017 Results - Earnings Call Transcript
11/02 62 Dividend Growth Stocks Going Ex-Dividend Next Week
Financials ($)
Sales 2017 5 250 M
EBIT 2017 1 780 M
Net income 2017 1 125 M
Debt 2017 3 675 M
Yield 2017 0,59%
P/E ratio 2017 31,87
P/E ratio 2018 27,11
EV / Sales 2017 7,32x
EV / Sales 2018 6,77x
Capitalization 34 773 M
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 72,7 $
Spread / Average Target 1,9%
EPS Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
Sector and Competitors